Assess online reaching motor control
- Trial ID
- NCT04616508
- Official Title
- Online Motor Control in People With Parkinson's Disease
- Goal
- Assess online reaching motor control
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- University of Delaware
- Study Type
- INTERVENTIONAL
- Enrollment
- 100 participants
- Conditions
- Motor Control, Parkinson Disease
- Interventions
- motor control assessment
Plain-Language Summary
The team wants to understand how Parkinson's affects online motor control, meaning the ability to make real-time corrections during a reach, which helps explain everyday problems with reaching and handling objects. Participants do measured reaching tasks of about 20 cm while researchers record how quickly and accurately movements are adjusted; people with Parkinson's must stay on their usual dopaminergic or dopamine agonist medication, so the results reflect medicated performance rather than a drug change. Adults 18 to 85 with an MMSE of 26 or higher who can reach about 8 inches are eligible, the Parkinson's group must self-report idiopathic PD and be taking dopaminergic medication, and anyone with other neurological disorders or upper-arm musculoskeletal issues is excluded.
Locations
- University of Delaware, Newark, Delaware, United States
Frequently Asked Questions
- What is this trial testing?
- This trial is studying motor control assessment. The team wants to understand how Parkinson's affects online motor control, meaning the ability to make real-time corrections during a reach, which helps explain everyday problems with reaching and handling objects. Participants do measured reaching tasks of about 20 cm while researchers record how quickly and accurately movements are adjusted; people with Parkinson's must stay on their usual dopaminergic or dopamine agonist medication, so the results reflect medicated performance rather than a drug change. Adults 18 to 85 with an MMSE of 26 or higher who can reach about 8 inches are eligible, the Parkinson's group must self-report idiopathic PD and be taking dopaminergic medication, and anyone with other neurological disorders or upper-arm musculoskeletal issues is excluded.
- Who can participate?
- Participants must be between 18 Years and 85 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 6 years.